Therapeutic interfering particles against HIV: molecular parasites reducing viremia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Therapeutic interfering particles against HIV: molecular parasites reducing viremia ; volume:9 ; number:1 ; day:14 ; month:10 ; year:2024 ; pages:1-3 ; date:12.2024
Signal transduction and targeted therapy ; 9, Heft 1 (14.10.2024), 1-3, 12.2024
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41392-024-02001-0
- URN
-
urn:nbn:de:101:1-2501012110335.600696844985
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gruell, Henning
- Odidika, Stanley
- Schommers, Philipp Frederik
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evolution of naturally arising SARS-CoV-2 defective interfering particles
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus
Cell culture-based production of defective interfering particles for influenza antiviral therapy
Cell culture-based production of influenza A virus-derived defective interfering particles
Mechanisms Contributing to Control of Viremia
Population dynamics of an RNA virus and its defective interfering particles in passage cultures
Interfering with sleep apnea
Clinical consequences of persistent low level viremia
In-depth characterization and cell culture-based production in influenza A virus defective interfering particles
Parasites
Parasites
Evolution of naturally arising SARS-CoV-2 defective interfering particles
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus
Cell culture-based production of defective interfering particles for influenza antiviral therapy
Cell culture-based production of influenza A virus-derived defective interfering particles
Mechanisms Contributing to Control of Viremia
Population dynamics of an RNA virus and its defective interfering particles in passage cultures
Interfering with sleep apnea
Clinical consequences of persistent low level viremia
In-depth characterization and cell culture-based production in influenza A virus defective interfering particles
Parasites
Parasites
Evolution of naturally arising SARS-CoV-2 defective interfering particles
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus
Cell culture-based production of defective interfering particles for influenza antiviral therapy
Cell culture-based production of influenza A virus-derived defective interfering particles
Mechanisms Contributing to Control of Viremia
Population dynamics of an RNA virus and its defective interfering particles in passage cultures
Interfering with sleep apnea
Clinical consequences of persistent low level viremia
In-depth characterization and cell culture-based production in influenza A virus defective interfering particles
Parasites